Innovator IBD Breakout Opportunities ETF (BOUT)

NYSEARCA: BOUT · Real-Time Price · USD

39.05

-0.01 (-0.02%)

At close: Nov 20, 2024, 1:50 PM

39.16

+0.11 (0.29%)

After-hours: Nov 20, 2024, 8:00 PM EST

-0.02% (1D)

Assets	$13.56M
Expense Ratio	0.85%
PE Ratio	25.34
Shares Out	350,000
Dividend (ttm)	$0.44
Dividend Yield	1.13%
Ex-Dividend Date	Jul 31, 2024
Payout Ratio	28.81%
1-Year Return	+28.13%

Volume	1,473
Open	39.07
Previous Close	39.06
Day's Range	38.78 - 39.07
52-Week Low	30.52
52-Week High	40.37
Beta	0.97
Holdings	44
Inception Date	Sep 13, 2018

About BOUT

Fund Home Page

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is issued by Innovator.

Asset Class Equity

Category Mid-Cap Growth

Region North America

Stock Exchange NYSEARCA

Ticker Symbol BOUT

ETF Provider Innovator

Index Tracked IBD Breakout Stocks Total Return

Top 10 Holdings

43.12% of assets

Name	Symbol	Weight
Block, Inc.	SQ	4.64%
Twilio Inc.	TWLO	4.64%
Morgan Stanley	MS	4.58%
Planet Fitness, Inc.	PLNT	4.52%
Guardian Pharmacy Services, Inc.	GRDN	4.44%
Expedia Group, Inc.	EXPE	4.43%
Upstream Bio, Inc.	UPB	4.03%
Liberty Broadband Corporation	LBRDK	3.96%
HealthEquity, Inc.	HQY	3.94%
CeriBell, Inc.	CBLL	3.93%